Wordt geladen...
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Schizophrenia is a chronic and debilitating neuropsychiatric disorder affecting approximately 1% of the world’s population. This disease is associated with considerable morbidity placing a major financial burden on society. Antipsychotics have been the mainstay of the pharmacological treatment of sc...
Bewaard in:
| Gepubliceerd in: | Curr Top Med Chem |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Bentham Science Publishers
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5112764/ https://ncbi.nlm.nih.gov/pubmed/27291902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1568026616666160608084834 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|